Bausch Health (BHC)

• Market cap: $2.75B
• 1 day: 0.40%
• 5 days: 0.40%
• 1 month: -0.13%
• 3 months: -8.57%
• 6 months: -1.32%
• Year to date: -5.92%
• 1 year: -9.12%
• 5 years: -74.87%
• 10 years: -95.24%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Employees: 20,270

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

14% more funds holding in top 10

Funds holding in top 10: 7 [Q2] → 8 (+1) [Q3]

6% more capital invested

Capital invested by funds: $1.96B [Q2] → $2.08B (+$115M) [Q3]

7.37% less ownership

Funds ownership: 76.65% [Q2] → 69.28% (-7.37%) [Q3]

10% less funds holding

Funds holding: 231 [Q2] → 208 (-23) [Q3]

34% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 68

44% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 48

71% less call options, than puts

Call options by funds: $41.8M | Put options by funds: $146M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $11 47% upside
• Avg. target: $11 47% upside
• High target: $11 47% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

RBC Capital Douglas Miehm 79% 1-year accuracy 15 / 19 met price target

47% upside $11

Sector Perform Maintained

1 Nov 2024